First Trust Advisors LP Dynavax Technologies Corp Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$11.7 - $14.98 $30.8 Million - $39.4 Million
2,628,622 Added 1397.8%
2,816,676 $35 Million
Q4 2023

Feb 13, 2024
SELL
$13.09 - $14.98 $1.48 Million - $1.69 Million
-112,848 Reduced 37.5%
188,054 $2.63 Million
Q3 2023

Nov 13, 2023
BUY
$12.64 - $14.99 $1.37 Million - $1.62 Million
108,397 Added 56.31%
300,902 $4.44 Million
Q2 2023

Aug 14, 2023
BUY
$9.85 - $13.17 $153,985 - $205,886
15,633 Added 8.84%
192,505 $2.49 Million
Q1 2023

May 15, 2023
SELL
$9.44 - $11.88 $984,356 - $1.24 Million
-104,275 Reduced 37.09%
176,872 $1.74 Million
Q4 2022

Feb 09, 2023
SELL
$10.27 - $13.29 $244,456 - $316,341
-23,803 Reduced 7.81%
281,147 $2.99 Million
Q3 2022

Nov 14, 2022
BUY
$9.93 - $17.44 $1.03 Million - $1.81 Million
103,936 Added 51.71%
304,950 $3.18 Million
Q2 2022

Aug 12, 2022
BUY
$7.45 - $12.83 $1.5 Million - $2.58 Million
201,014 New
201,014 $2.53 Million
Q3 2018

Oct 25, 2018
SELL
$11.85 - $16.0 $458,559 - $619,152
-38,697 Closed
0 $0
Q2 2018

Aug 02, 2018
SELL
$15.15 - $20.75 $526,204 - $720,709
-34,733 Reduced 47.3%
38,697 $590,000
Q1 2018

Apr 23, 2018
SELL
$14.65 - $19.9 $483,039 - $656,142
-32,972 Reduced 30.99%
73,430 $1.46 Million
Q4 2017

Feb 08, 2018
BUY
$17.3 - $24.08 $1.84 Million - $2.56 Million
106,402
106,402 $1.99 Million

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email